Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-23

GLP studies de risked which are end of June for finalisation leading into phase 1 and leading into Walter reed results which is also de risked

But near term this week or next expect some news flow from pre clinical brain cut outs

Im not a pip trader. To have 10 million dollars of cash and being a 14 million dollar market cap for a biotech that’s already de risked and working, together with the fact CEO and directors invest their 250k at around 8 cents on May 16th. Yeh it’s pretty laughable. But I bought more and aiming to have 3.5 million shares over next two weeks for accumulation for the coming period and then leading into FDA submission in Jan/Feb next year. It’s easily predicted on this pull back but should never be trading at this valuation when AGN was trading at a 100 million dollar market cap pre clinical on potential. 4 million dollar EV funny